Skeptical Druggist

Administer 500mg orally twice daily with food. Contraindicated in patients with severe hepatic impairment or hypersensitivity to the active ingredient.

The randomized, double-blind, placebo-controlled trial demonstrated statistically significant improvement in primary endpoints with a p-value of 0.003.

Common adverse reactions include gastrointestinal disturbances, transient elevation of hepatic enzymes, and occasional photosensitivity reactions.